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NMRPolar lipids and membrane proteins are major components of biological membranes, both cell membranes and
membranes of enveloped viruses. How these two classes of membrane components interact with each other
to inﬂuence the function of biological membranes is a fundamental question that has attracted intense interest
since the origins of the ﬁeld ofmembrane studies. One of themost powerful ideas that driven the ﬁeld is the like-
lihood that lipids bind to membrane proteins at speciﬁc sites, modulating protein structure and function. How-
ever only relatively recently has high resolution structure determination of membrane proteins progressed to
the point of providing atomic level structure of lipid binding sites on membrane proteins. Analysis of X-ray
diffraction, electron crystallography and NMR data over 100 speciﬁc lipid binding sites on membrane proteins.
These data demonstrate tight lipid binding of both phospholipids and cholesterol to membrane proteins. Mem-
brane lipids bind tomembrane proteins by their headgroups, or by their acyl chains, or binding ismediated by the
entire lipid molecule. When headgroups bind, binding is stabilized by polar interactions between lipid
headgroups and the protein. When acyl chains bind, van der Waals effects dominate as the acyl chains adopt
conformations that complement particular sites on the rough protein surface. No generally applicable motifs
for binding have yet emerged. Previously published biochemical and biophysical data link this binding with
function. This Article is Part of a Special Issue Entitled: Membrane Structure and Function: Relevance in the Cell's
Physiology, Pathology and Therapy.
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The membranes of cells (and enveloped viruses) are built largely
from membrane proteins and lipids. What effects each membrane
component may have on the other, and how they interact to modulate
function in, on, and around biological membranes, have tantalized
researchers for several decades. It is now possible to synthesize new
data from three dimensional structures of membrane proteins withbrane Structure and Function:
.
ights reserved.prior data from biophysical experiments to begin to answer the long-
standingquestions of the nature and extent of lipid–protein interactions
in biological membranes, and what roles those interactions may play in
biological membrane function.
In themost simple view, biological membranes can be considered to
consist of two major classes of molecules: membrane lipids and
membrane proteins. Three linked interactions must be considered in
such a two component system: lipid–lipid interactions, protein–protein
interactions, and lipid–protein interactions. These three sets of interac-
tions are not independent. Perturbations in any one of these linked
interactions can be expected to affect the other two. Protein–protein
interactions are known from extensive studies with soluble proteins
Table 1
Number of lipid binding sites in X-ray crystal structures of membrane proteins.
Lipid PDB ID Protein #
bound
Cholesterol 3AM6 H+ pump rhodopsin ARII 2
2YOO Turkey β1-adrenergic receptor 2
2RH1, 3D4S Human β2-adrenergic receptor partial
inverse agonist
2
3PDS Human β2-adrenergic receptor agonist 1
4EIY Human A2A (bRIL) adenosine receptor 3
4DKL Mouse μ-opiod receptor antagonist 2
4IB4 Human 5-HT2B ERG 1
4HYT Porcine Na+K+ATPase ouabain
phosphorylated
1
2ZXE Shark Na+K+ATPase FXYD 1
EMD-1079 Bovine rhodopsin 1
2BG9 Torpedo nicotinic acetyl choline receptor
(model into electron density)
1
DPG 2C3E, 1OKC Bovine mitochondrial ADP/ATP carrier CATR 3
1PPG Bovine mitochondrial cytochrome bc1,
antimycin
1
1KB9, 1P84 Yeast mitochondrial cytochrome bc1, inhibitor 1
2DYR, 1V54 Bovine heart cytochrome c oxidase 2
4AYT Human mitochondrial ABC transporter 2
1NEK E. coli succinate dehydrogenase 1
1KQF Formate dehydrogenase N 1
1OGV,
1QOV
Photosynthetic rxn ctr R. sphaeroides 1
4A2N Ma-ICMT 1
1M3X R. sphaeroides photosynthetic rxn center 1
1V54 B. tau cytochrome c oxidase 2
PG 1OCC Bovine heart cytochrome c oxidase 3
2DYR Bovine heart cytochrome c oxidase 4
2AXT T. elongatus photosystem II 1
1JBO S. elongatus photosystem 1 3
3LNM Kv2.1–Kv1.2 chimera potassium channel 1
2R9R Kv2.1–Kv1.2 chimera potassium channel N2
4DOJ BetP transporter 1
4JBW Maltose transporter 1
1V54 B. tau cytochrome c oxidase 3
PE 1KB9 Yeast mitochondrial cytochrome bc1, inhibitor 2
1P84 Yeast mitochondrial cytochrome bc1, inhibitor 3
1BCC Avian cytochrome bc1 2
1PPJ Bovine cytochrome bc1 inhibitor 2
1M56 R. sphaeroides cytochrome c oxidase 6
2DYR, 1OCC Bovine cytochrome c oxidase 3.5
1QOV R. sphaeroides photosynthetic rxn center 1
1ZOY,
2FBW
Porcine mitochondrial respiratory complex II 2
1EYS T. tepidum photosynthetic rxn center 1
1XIO Anabaena sensory rhodopsin N4
1GZM Bovine rhodopsin 1
3W5A Rabbit Ca pump sarcoplasmic reticulum 3
3ZUY Bacterial Na+ bile acid cotransporter 2
2ZZ9 Aquaporin 5
1V54 B. tau cytochrome c oxidase 3
1NEK E. coli cytochrome c oxidase 1
PI 1KB9 Yeast mitochondrial cytochrome bc1, inhibitor 1
PIP2 3SYA Mammalian GIRK2 potassium channel 1
PC 2DYR Bovine heart cytochrome c oxidase 1
1P84 Yeast mitochondrial cytochrome bc1, inhibitor 2
1KB9 Yeast mitochondrial cytochrome bc1, inhibitor 1
1OKC Bovine mitochondrial ADP/ATP carrier 2
2Z73 Squid rhodopsin 1
3AYN Squid isorhodopsin 1
3B8E Porcine renal Na+K+ATPase 1
4AW6 Zinc metalloprotease, ZMPSTE24 1
3RVY Voltage gated channel NavRh 1
4EKW Voltage gated channel NavRh 4
2B6O Aquaporin Annulus
2XTV E. coli rhomboid protease GLPG Annulus
1QLE P. den. cytochrome c oxidase 2
1V54 B. tau cytochrome c oxidase 1
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interactions can affect the milieu in which the membrane proteins
function (for example, a phase transition of the lipids to a gel state or
the incorporation of high levels of cholesterol in the membrane, either
of which will inactivate most transmembrane enzymes). Since in a bio-
logical membrane one may ﬁnd dozens of unique membrane proteins
and hundreds or thousands of unique membrane lipids, structure and
function in the biological membrane are inherently more complex
than just outlined. However, such a construct offers a useful structure
with which to approach our subject. This review, therefore, will focus
on lipid–protein interactions. Lipid–protein interactions, as just noted,
can be affected by lipid–lipid interactions and protein–protein interac-
tions. However because the former have been less intensively examined
(due to lack of adequate experimental approaches), the focus will be on
lipid–protein interactionswhile remaining cognizant of the other linked
interactions.
Lipid–protein interactions will often inﬂuence membrane protein
function. Lipids may force a protein conformational change to bury the
hydrophobic surfaces of the membrane protein within the limited
thickness of the hydrophobic interior of the membrane lipid bilayer.
This can be particularly dramatic if a substantial hydrophobic mismatch
occurs between thewidth of the hydrophobic surface of the transmem-
brane domain and the width of the bilayer. Transmembrane proteins
express a hydrophobic surface on the transmembrane portion of the
protein to coexist with, and match the dimensions of, the hydrophobic
interior of the membrane bilayer. If the dimensions of the hydrophobic
surface on themembrane protein are similar to the width of the hydro-
phobic interior of the bilayer, then these two components can ﬁnd a
ready accommodation. If however the protein is in a bilayer that is
thinner than the hydrophobic surface on the protein, the protein may
alter conformation (such as a tilt [1–3] or a bend [4,5] in the trans-
membrane portion) to better accommodate the hydrophobic portion
of the bilayer, or the bilayer may distort to cover the hydrophobic
surface on the transmembrane protein [6,7].
Lipids also can act as effectors that bind and alter membrane protein
function. This role is analogous to effectors binding to soluble proteins in
solution and inducing a change in protein function. Since the transmem-
brane proteins are in part within the lipid bilayer and the effective “con-
centration” of the lipids (solvent) in two dimensions within the bilayer
is very high, any binding sites on the protein that canmatch the proper-
ties of one or more membrane lipids can be expected to be occupied by
those lipids to some extent. The extent may be dependent upon protein
conformation and therefore binding of these lipids can induce changes
in membrane protein conformation and consequent changes in mem-
brane protein function.
This latter set of possibilities has engendered considerable hypothe-
sizing and experimenting. The opportunity for speciﬁc lipids to bind to
particular membrane proteins and affect their function is a compelling
concept. Such a concept would begin to provide an explanation for the
observation of so many individual lipid species in most biological mem-
branes. Until recently the paucity of atomic level structural information
on membrane proteins considerably limited the ability of investigators
to address this question directly. Prior to the availability of such detailed
structural information, a number of (mostly) indirect experimental
approacheswere creatively applied that produced considerable support
for a role of lipid binding to membrane proteins in regulation of mem-
brane protein function (see for example, [8–12]). Recently considerable
new information on atomic structure of transmembrane proteins has be-
come available. Integrating those structural data with the previous bio-
physical data allows a much more extensive and satisfying exploration
of the extent, nature and role of lipid–protein interactions inmembranes.
Compared to a decade ago, there is now an abundance of structural
data, in particular from X-ray crystallography, on lipid binding to mem-
brane proteins. There are currently over 100 individual examples of a
particular lipid binding to a particular membrane protein from X-ray
crystal structures of transmembrane proteins (see Table 1). Below, thetext will focus on individual classes of lipids, one at a time, that bind
to membrane proteins and explore what is known for each of those
lipids from X-ray crystallography data. Most earlier reviews on this
Fig. 1.X-ray crystal structure of theporcine Na+K+ATPase (PDB ID: 4HYT) in gray. Choles-
terol molecules in the crystal are shown in green.
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data, and, for the most part, organized their discussion around
individual membrane proteins and what lipids bound to them.
The recent X-ray data provide for a more detailed examination
of lipids binding to membrane proteins than previously possible.
Binding of cholesterol and phospholipids, only, to membrane pro-
teins will be discussed here. They account for most of the available
data.
As we consider the available data in this review, several themes will
emerge from an analysis of the structural information. Somemembrane
phospholipids and/or cholesterol bind to the transmembrane domain
of membrane proteins so tightly that they are not removed by the
delipidation treatments used to prepare the samples. These sites often
appear in X-ray crystal structures of membrane proteins occupied by a
particular membrane lipid. Many if not most of these sites for tightly
bound membrane lipids are likely speciﬁc for the chemical structure of
the particular lipid. Tight binding of these lipids is expected to inﬂuence
membrane protein structure, and likely function. Biochemical data
support the functional role in a number of examples. Most frequently,
one to six lipids are bound so tightly to these sites that the detergent
isolation techniques do not remove them. These sites may be on the
surface of the transmembrane domain. They may be buried within the
helical bundle of a transmembrane protein. They may occur between
monomers in the crystal structure. In many X-ray structures of trans-
membrane proteins, detergents are included in the electron density.
It is possible that some of these detergent molecules may be occup-
ying sites normally occupied by membrane lipids in the biological
membrane.
One limitation should be noted at the beginning of this discussion.
The experiments are mostly performed on rigorously delipidatedmem-
brane proteins. Usually detergents are used to remove the membrane
lipids and other membrane components so that the investigator can
work with puriﬁed protein and thus hope to crystallize it. The only
phospholipids and cholesterol that appear inmost of these crystal struc-
tures are thereforemolecules that are so tightly bound to themembrane
protein that extensive detergent treatment does not remove the lipid.
This leaves open the likelihood that other lipid binding sites exist that
can be depleted of lipid by detergent treatment and therefore are not
observed in the crystal structure. Also missing from the X-ray crystal
structures will be those lipids whose binding is dynamic such that an
ordered lipid in a binding site over the timescale of the X-ray diffraction
experiment is not seen.
Other techniques like NMR (nuclear magnetic resonance) and ESR
(electron spin resonance of lipid spin labels) allow measurements of
lipid–protein interactions in biological membranes, without isolation
of the membrane protein, thus reﬂecting best the biology. These tech-
niques are used as well as in reconstituted membranes in which case
during sample preparation membrane lipids are removed and deﬁned
lipids are added back. These measurements reveal that a larger number
of membrane lipids are interacting with the protein, beyond the one to
six described above. Perhaps double that number can be bound at sites
on the protein sufﬁciently strongly to be detected by 31P NMR. With
ESR measurements, even more lipids may be identiﬁed, enough to
completely surround the protein (the lipid annulus). Most of the latter
lipids are not tightly bound and exchange rapidly with other lipids in
the membrane.
In some cases, data are derived from multiple disciplines, as just
noted. The discussion will include only those phospholipids for which
atomic level data on binding are available from X-ray crystallography
or electron crystallography (or in one case, NMR). For some of the lipids
that bind to membrane proteins, other biophysical data are available
that precede the X-ray crystallography data and also provide
structural evidence for lipid binding. Some of those data will be
included in the discussion, data that can now be better understood
and that extend our knowledge of lipid–protein interactions in
membranes.2. Cholesterol
Cholesterol is an amphipathic molecule with a polar hydroxyl
bonded to four planer fused carbon rings and a short hydrocarbon tail.
Cholesterol has a ﬁnite but very low solubility in aqueous media so it
is usually found incorporated in biological membranes or lipoproteins
or bound to proteins, both soluble proteins and membrane proteins.
Cholesterol is an unusually important lipid for mammalian
membranes. Most mammals require cholesterol in many of their cell
membranes for survival. Sterols closely related in chemical structure
(for example epicholesterol) are unable to substitute for this cholesterol
requirement. A number of plasmamembrane ion pumps are dependent
upon cholesterol. Depletion of the plasmamembrane of cholesterol ren-
ders these ion pumps inactive. That includes the Na+K+ATPase, which
in many cells is the single most important consumer of ATP in the cell
and is responsible for transmembrane ion gradients upon which many
cellular functions depend. (Many membrane enzymes lose activity at
very high membrane cholesterol content. This is, however, due to
another, separate property of cholesterol: at high levels it increases
the motional order of the membrane lipids. At high order, trans-
membrane permeability is reduced and conformational ﬂexibility of
the transmembrane protein is inhibited.)
A hypothesis was previously advanced that the cholesterol depen-
dency arose from cholesterol binding to speciﬁc sites on certain mem-
brane proteins [18]. The Na+K+ATPase provides a case study of this
hypothesis, from structural data to stability data to biochemical data
[19,20].
A recent X-ray crystal structure of the phosphorylated pig kidney
Na+K+ATPase with ouabain bound reveals a cholesterol binding site
on the transmembrane portion of the protein between the γ andα sub-
units [21] (Fig. 1). This site is close to a suggested phospholipid binding
site (see below). Together binding of these two lipids to these sites on
1551P.L. Yeagle / Biochimica et Biophysica Acta 1838 (2014) 1548–1559the Na+K+ATPase stabilizes activity of the enzyme. The cholesterol
binding site is speciﬁc for cholesterol; ergosterol is not as effective
as cholesterol in stabilization of enzyme activity. An earlier study
examined the effects of membrane cholesterol content in a biological
membrane on Na+K+ATPase activity. Increasing cholesterol from low
concentrations in the membrane promoted increasing enzyme activity
up to the nativemembrane cholesterol level (extrapolating to zero cho-
lesterol content suggested that in the absence of cholesterol the enzyme
was inactive). Other sterolswere unable to duplicate these activating ef-
fects of cholesterol [22]. All these data can be better understood in the
light of the new structural information. As the early biochemical data
suggested, the Na+K+ATPase has a cholesterol binding site which
is speciﬁc for the cholesterol molecule. It is reasonable to speculate
based on these studies that occupancy of this cholesterol binding site
by cholesterol promotes and stabilizes activity of this important plasma
membrane enzyme. Therefore, cholesterol does bind to at least one
transmembrane protein at a site speciﬁc for cholesterol, altering the
properties of the protein. Such results begin to describe a speciﬁc and
critical role for one membrane lipid in membrane function through
lipid–protein interactions.
There are data that cholesterol binds to other transmembrane pro-
teins aswell. The transmembrane domain of the amyloid precursor pro-
tein has a cholesterol binding site. In this case, the three dimensional
structure was determined from nuclear magnetic resonance (NMR)
data. Titrations with cholesterol not only identiﬁed which amino acid
residues formed the binding site but also revealed some information
about the afﬁnity of the binding site for cholesterol [23].
The class of G-protein coupled receptors (GPCR) shows cholesterol
binding to the receptor in the recent set of X-ray crystal structures of
this family of membrane receptors. In each case, one to two cholesterol
molecules are found in binding sites on the transmembrane portion of
the receptor.
Humanβ2 adrenergic receptor has been successfully crystallized and
its atomic resolution structure determined. Cholesterol is found bound
at the interface between twomonomers of the receptor [24]. Cholester-
ol is known to affect the function of this receptor, but whether that oc-
curs by promoting association of two receptor monomers as the crystal
structure suggests, or perhaps keeps themonomers apart, is not known.
In a more recent crystallographic analysis [25], two binding sites for
cholesterol are found, at sites separate from the protein–protein inter-
face described above. These latter have been suggested to be candidate
sites for known effects of cholesterol on the receptor function, including
effects on ligand binding and thermal stability. The cholesterol binding
sites in the structure of the receptor are in the transmembrane region,
next to helices I, II, III, and IV, on one face of the transmembrane domain.
The suggestion ismade that binding of cholesterol increases the packing
density of the transmembrane helical bundle, thus increasing the
thermal stability of the molecule.
Other GPCR also have cholesterol (or analog) binding sites. Turkeyβ1
adrenergic receptor shows a binding site for cholesterol hemisuccinate
[26].
The crystal structure of the proton pumping rhodopsin, ARII, shows
two cholesterol binding sites, bounded by helices I and VII of one
protein, and helix I of an adjacent protein in the crystal [27].
The structure of the human A2A adenosine receptor contains three
cholesterol binding sites. While two are at crystal contacts, one choles-
terol is not. Cholesterol binding at the latter site is suggested to stabilize
the transmembrane helical bundle, much like the case of the human β
adrenergic receptor, and possibly orient a key residue in the ligand
binding pocket of the receptor [28].
One cholesterol binding site is seen in the μ-opiod receptor [29]. The
binding site is boundedby two transmembranehelices fromone receptor
molecule and one fromanother, much like the ARII receptor. Biochemical
evidence shows a sensitivity of the receptor function to cholesterol
in the membrane, and furthermore shows that the site of binding can
discriminate sterol structure [30].The 5-HT2BERG receptor also has a binding site for one cholesterol
[31].
Finally, no discussion of GPCR and cholesterol would be complete
without mention of bovine rhodopsin. Rhodopsin function in mem-
branes is inhibited by the presence of high levels of membrane choles-
terol [32]. This GPCR exhibits a binding site for cholesterol in the
electron crystallography data [33]. The site is next to helix VI, close to
a phospholipid binding site. Fluorescence experiments with a ﬂuores-
cent derivative of cholesterol are consistent with a binding site on the
transmembrane domain of the protein speciﬁc for the cholesterol struc-
ture, near a tryptophan (helix VI includes a tryptophan) [34]. Molecular
calculations also provide support for cholesterol binding to the trans-
membrane domain of rhodopsin [35]. Cholesterol inﬂuence on rhodop-
sin behavior is well studied [32,36,37].
In summary, X-ray crystallographic data shows that cholesterol
binds to a number of membrane proteins at speciﬁc sites. This binding
provides a mechanism for cholesterol to inﬂuence transmembrane
protein conformation and thus transmembrane protein function.
These observations are consistent with the previous suggestion that
the speciﬁc effects of cholesterol on biological membrane function are
mediated by binding tomembrane proteins. Enough data are now avail-
able to form the basis for targeted investigations to detail the molecular
mechanisms by which cholesterol effects its inﬂuence through binding
to the protein structure (these effects of cholesterol through binding
to membrane proteins are separate and independent from the effects
on membrane proteins due to the ordering by cholesterol of the lipid
bilayer in which the membrane proteins are found).
3. Diphosphatidylglycerol (cardiolipin)
Diphosphatidylglycerol (DPG), or cardiolipin, is a highly negatively
charged phospholipid that is a major component of, for example,
the inner mitochondrial membrane. The chemical structure of DPG is
more complex than the other lipids that will be discussed here. It has
4 acyl chains esteriﬁed to one headgroup that contains two phosphates
that confer the negative charge.While in biology one normally thinks of
this phospholipid inmembrane bilayers, in pure form in the presence of
some cations, DPG is unstable in the bilayer structure and instead forms
non-bilayer structures including the Hexagonal II phase [38]. In the
inner mitochondrial membrane, DPG is present at about 20% of the
lipids [39] and the membrane is in the form of a bilayer.
In the inner mitochondrial membrane, DPG plays critical roles in
structure and in function. Recent X-ray crystallographic analysis has
revealed DPG binding sites on several transmembrane proteins in the
inner mitochondrial membrane.
The ADP/ATP carrier protein is one transmembrane protein that
binds DPG. The ADP/ATP carrier is responsible for transport of ADP
into the mitochondria for oxidative phosphorylation to ATP which is
then transported out of the mitochondria for use as a cellular fuel.
Three DPG molecules are found bound to the bovine ADP/ATP carrier
in the crystal structure [40] (Fig. 2). The phosphates are coordinated
to backbone nitrogens. 31P NMR experiments on bovine ADP/ATP carri-
er also demonstrated the tight binding of DPG to the ADP/ATP carrier
protein [41]. (31PNMR is a non-perturbingmeans tomonitor the behav-
ior of the phosphorus in the polar headgroups of phospholipids.) Six
DPG were found to be bound. The techniques used for preparation of
the samplemay have been less perturbing than the detergent extraction
used for the crystallography, perhaps explaining the higher number of
DPG molecules bound. Biochemical experiments suggest possible roles
for DPG in stability of the carrier but apparently more experimentation
is required to rigorously establish the nature of the biological role
[42,43].
DPG has also been found bound to the yeast cytochrome bc1 com-
plex from the inner mitochondrial membrane. This enzyme catalyzes
electron transfer from ubiquinol to cytochrome c. One DPG is bound
and appears to play a role in the biological function [44]. One of its
Fig. 2. X-ray crystal structure of bovine ADP/ATP carrier (PDB ID: 2C3E) in blue, showing
DPG molecules bound to the protein.
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the other phosphate in part through a water molecule to a lysine.
The side chain of a tryptophan is in close proximity to the acyl chains
of the DPG. These interactions help stabilize the binding of the
amphipathic DPG to the protein. Recent molecular calculations
on cytochrome bc1 in a lipid environment are in agreement with the
X-ray crystal structure in ﬁnding the same DPG binding site and, in
addition, suggest 5 other binding sites for DPG on the protein [45].
Cytochrome c oxidase, found in the inner mitochondrial membrane,
catalyzes the ﬁnal electron transfer to water of the mitochondrial elec-
tron transport chain. DPGbinds to cytochrome c oxidase and its removal
leads to loss of activity which can be restored by addition of DPG [46]. In
an X-ray structural analysis of bovine heart cytochrome c oxidase, two
DPG are found bound, both in the transmembrane domain [47]. One
DPG bridges two monomers to stabilize a dimer. The other DPG binds
near subunit III. The acyl chains of the DPG adopt particular conforma-
tions in their binding sites, accommodating to the rough surface of the
protein. The phosphates are stabilized by interactions with hydrogen
bond donors from the protein.
ABC10 is an ATP-binding cassette (ABC) transporter in the inner mi-
tochondrialmembrane. X-ray structural analysis shows that DPG bound
to the transmembrane domain of the protein [48]. Interestingly, some of
the acyl chains of the DPG are intercalated among the transmembrane
helices of the protein.
Formate dehydrogenase-N (Fdn-N) is a component of Escherichia
coli nitrate respiration. In the crystal structure, one DPG is bound to
a site on the transmembrane subunit [49]. The site is at the trimer inter-
face. The headgroup of the DPG is hydrogen bonded to serine, aspara-
gine on one subunit and threonine on another.
Succinate dehydrogenase catalyzes the oxidation of succinate to
fumarate coupled to the reduction of ubiquinone. In the X-ray crystal
structure, DPG is found bound to the transmembrane domain of this
membrane protein [50]. DPG is also found bound to the transmembrane
domain of isoprenylcysteine carboxyl methyltransferase [51].
The photosynthetic reaction center, Rhodobacter sphaeroides,
contains a binding site for one DPG. The X-ray crystal structure shows
that a DPG molecule is bound to the transmembrane domain. The neg-
atively charged headgroup of theDPG is stabilized by interactionswith a
positively charged arginine, lysine, and histidine [52]. These residuesappear to be conserved across species [53]. The acyl chains contact
two subunits, contributing to stabilization of the protein structure,
essentially providing a means of binding the subunits together by the
phospholipid.
Experimental evidence shows that DPG binds to a number of mem-
brane proteins, particularly in those membranes involved in electron
transport. By binding, the DPG is able in some cases to facilitate associ-
ation of one protein subunit to another (by binding onemore of its acyl
chains to each of the subunits), thus stabilizing the structure of a com-
plex of multiple subunits. In fact, DPG may be critical in the formation
of supercomplexes in mitochondrial membranes [54,55] even while
the speciﬁc roles in function remain to be clariﬁed. Perhaps as a conse-
quence, the fatty acyl chain composition of the DPG is well deﬁned in
these membranes.
In other cases, DPGwith itsmultiply-charged headgroup can directly
play a role in membrane protein function. The headgroup can form
resonance structures that can absorb and release a proton. This concept
gains credence as a possible role for DPG in the observation that in some
cases the DPG headgroup is found near a catalytic site in the structure of
the protein.
4. Phosphatidylglycerol
Phosphatidylglycerol (PG) is typical of many phospholipids in that it
contains two acyl chains esteriﬁed to a glycerol, which in turn is bonded
to a headgroup structure that contains net charges. PG contains one
phosphate in its headgroup and no other groups with compensating
positive charges (the remaining structure is a glycerol). PG therefore
has a net negative charge and thus introduces negative charge into a
membrane surface and to the lipid–protein interface.
In one of the transmembrane protein structures already introduced,
cytochrome c oxidase, 4 PG are found bound in the crystal structure [47].
The headgroup of PG is not well resolved in this structure so it is difﬁcult
to determine the contacts between the phospholipid headgroup and the
residues of the protein. However, the electron density describing the acyl
chains of the PG binding to the protein is deﬁned. The PG acyl chains
adopt particular conformations on the protein hydrophobic transmem-
brane surface. Those conformations are driven by the acyl chains
conforming to the rough (on the atomic scale) protein surface sculptured
by the size and shapes of the various hydrophobic amino acid side chains.
It is interesting that these chains appear to bind to sites with some con-
servation of structure. The acyl chains of the PG adopt a nearly superim-
posable conformation on the surface of this protein in structures of
cytochrome c oxidase from different species. In an interesting variant,
PG in some sites is bound with their acyl chains within the transmem-
brane bundle of alpha helices. That is, the acyl chains ﬁnd their way
into sites among the transmembrane helices, not just to sites on the
surface of the transmembrane bundle of helices of the protein (Fig. 3).
Such partially buried sites likely affect the stability of the transmembrane
domain of the protein. Finally, some lipids are bound at the interface
between subunits in the X-ray crystal structure [56].
Photosystem II is involved in photosynthesis. Photosystem II cata-
lyzes the light-driven oxidation ofwater. In contrast to PG binding to cy-
tochrome c oxidase, PG binding to photosystem II is characterized by
well-deﬁned headgroups bound to the protein, indicating high afﬁnity
binding mediated by PG headgroup structure. In support of this, the
binding site for the headgroup contains arginine, threonine, and aspar-
agine, residues that are conserved. These residues offer a positively
charged region on the protein compatible with the negatively charged
phosphate in the PG headgroup [57].
PG also binds to photosystem I which catalyzes another part of the
photosynthesis reaction. PG binding to photosystem I is well deﬁned
in the density map. Three PG molecules are bound. The headgroups
are in some cases near the chlorophylls. Some of the PG acyl chains
are bound between protein subunits in the transmembrane domain of
the protein [58,59].
Fig. 3. X-ray crystal structure of bovine heart cytochrome c oxidase (PDB ID: 2DYR) in gray, showing phospholipids in green. A. Side view showing phospholipids in a conﬁguration
approximating a bilayer. B. Top view showing some phospholipids partly intertwined with the helices of the transmembrane domain of the protein.
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membrane channel proteins. Channel proteins provide a means for
small molecules or ions to transverse a membrane that the lipid bilayer
would otherwise render impermeable. TheX-ray crystal structure of the
voltage dependent potassium channel provides an interesting exam-
ple [60,61]. Possibly because the protein was crystallized from mixed
micelles of PG and phosphatidylethanolamine, a number of phos-
pholipids are found in the structure. All the electron density of the
well-deﬁned phospholipid sites have been modeled with PG (though
whether PE might occupy some sites probably cannot be ruled out).
Overall the phospholipids organize to approximate a bilayer, with mol-
ecules of PG occupying sites on both sides of the putative bilayer struc-
ture. However closer inspection reveals that considerable variation in
PG location is observed. This is likely due to speciﬁc interactions be-
tween amino acid side chains on the channel and headgroup structures
in the phospholipid. One feature in particular is revealed by this crystal
structure: there are likely more sites for interactions between mem-
brane proteins and membrane lipids than the relatively rare onesobserved on severely delipidated (by detergent treatment) proteins
already discussed in this review. The latter sitesmay just be lower afﬁnity
sites that are more readily displaced by detergents used in puriﬁcation.
PG also binds to the betaine transporter, BetP. The binding site is
between protein subunits with one acyl chain contacting one subunit
and the other acyl chain contacting the other subunit [62].
One further example of PG binding to a membrane transporter pro-
tein is themaltose transporter. PG is bound at a site between two trans-
membrane helices of one subunit with the headgroup at the putative
membrane–aqueous interface. The binding site does not appear to be
between subunits [63].
PG binding to transmembrane proteins shows much of the range of
interactions exhibited by DPG binding to transmembrane proteins. In
some cases the PG headgroup is the best deﬁned part of the phospho-
lipid, suggesting a fairly speciﬁc and tight interaction between the PG
headgroup and the site on the protein. These headgroup-speciﬁc sites
in some cases contain hydrogen bond donors and positive charges that
may stabilize the interactionwith the negatively charged PG headgroup.
Fig. 4. X-ray crystal structure of Anabaena sensory rhodopsin (PDB ID: 1XIO) in cyan.
Bound PE acyl chains appear in blue. The PE headgroups are not well deﬁned. The identity
of the phospholipid is made by chemical analysis since the unique structure of the PE
headgroup cannot be seen in the electron density.
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structures, suggesting strong interactions between these portions of
the lipid and the surface of the protein. In some cases the acyl chains
of one PG contact more than one subunit and may stabilize the overall
structure of a multisubunit protein.
5. Phosphatidylethanolamine
The phosphatidylethanolamine (PE) headgroup is a zwitterion, with
a phosphate (negative charge) and a free amine (positive charge).
PE shares with DPG the ability to form pure lipid structures different
from the phospholipid bilayer. Speciﬁcally, many forms of PE readily
adopt the Hexagonal II structure [64]. While PE carries two charges, in
a mixed phospholipid bilayer (with another phospholipid component
that stabilizes the bilayer structure) the PE headgroup is strongly hydro-
gen bonded intermolecularly to an immediate neighbor phospholipid.
This forms an ion pair between the positively charged amine of one
phospholipid and the negatively charged phosphate of a neighbor phos-
pholipid. This close favorable interaction greatly diminishes the polar
character of the headgroup and the corresponding membrane surface,
and facilitates the formation of non-bilayer phases as well as interac-
tions with membrane proteins.
X-ray crystallography reveals two (or three) binding sites for PE on
cytochromebc1. Interactions between theprotein and the PE aremanifest
for both the headgroup and the acyl chains. For one of the headgroups,
the amine of the PE is hydrogen bonded to the carboxyl of a glutamic
acid side chain. The phosphate is coordinated to two tyrosine hydroxyls
and to an ordered water that is turn hydrogen bonded to a tryptophan.
The acyl chains make close contacts to a number of aromatic amino
acids [44,65–67].
PE also binds to cytochrome c oxidase [47,56]. In one X-ray crystal
structure of R. sphaeroides cytochrome oxidase, six molecules of PE are
found in deﬁned binding sites [68]. Two of the PE are bound in a cleft
created by transmembrane helices of the protein. The other four PE
are bound between subunit IV and subunits I and III. In these sites, PE
appears to play a role in the association between subunit IV with the
rest of the complex. Binding of PE headgroups to another cytochrome
c oxidase had been previously observed through 31P NMR experiments,
in which 3–8 PE molecules were found bound, similar to the observa-
tion in the above X-ray crystal structure [69].
Two PEmoleculeswere foundbound to themitochondrial respirato-
ry complex II in theX-ray crystal structure [70,71]. Both of these binding
sites extend the acyl chains along the axis of the transmembrane
domain of the protein. The acyl chains of the PE have amore deﬁned in-
teractionwith the protein than the phospholipid headgroup, in contrast
to cytochrome c oxidase described above.
One PE molecule is found bound in the X-ray crystal structure of
Thermochromatium tepidum photosynthetic reaction center [72]. The
binding site is on the transmembrane domain of the protein. In this
case the headgroup of the PE is in a distinct binding site created in
part by an arginine and a lysine (which can favorably interact with the
PE phosphate). The acyl chains bind in a cleft between the transmem-
brane helix of the H subunit and the transmembrane helices of the L
and M subunits of the protein.
Anabaena sensory rhodopsin in its X-ray crystal structure binds a
number of PE molecules [73]. Some sites appear to be at the interface
between proteins in the crystal and some sites are on the surface
of the transmembrane domain interacting with only the monomer.
Speciﬁc interactions between residues and the phospholipid are not
reported. The headgroups are not well deﬁned in the electron density
while the acyl chains are (Fig. 4).
Bovine rhodopsin is the photosensitive pigment in rod cells respon-
sible for black and white at low light levels. Rhodopsin functions in a
membrane rich in PE. It is not surprising then to ﬁnd, even for a trans-
membrane protein that has been extensively delipidated, a PEmolecule
bound in the X-ray crystal structure (though the identiﬁcation of thislipid molecule as PE is somewhat ambiguous). The binding site for the
acyl chains, which are well deﬁned, is between helices 6 and 7. The
headgroup is not visualized in the crystal structure [74].
Bovine rhodopsin of the retinal rod outer segment disk is a highly
studied system, and several independent biophysical techniques have
been employed to study the lipid–protein interactions in this system.
The disk membrane is relatively simple in composition in that 90% of
the protein in the membrane is rhodopsin. Rhodopsin therefore is a
good subject to explore what techniques other than X-ray crystallogra-
phy can tell us about lipid–protein interactions in this system. 31P NMR
measurements (which reﬂect primarily the behavior of the phospholip-
id headgroups) are among the few biophysics approaches that allow
study in the intact rod outer segment disk membranes. These experi-
ments revealed a subcomponent of the membrane phospholipid that
is bound to the protein (at least in the headgroup region)while thema-
jority of the phospholipid is in a bilayer structure [75–77]. While the
composition of this bound component could not be determined at the
time, it likely contains PE and PC, the two major phospholipids of the
diskmembrane. About 20phospholipidswere foundboundper rhodop-
sin. Electron spin resonance measurements with lipid spin labels also
sense two different lipid environments, one relatively immobilized
and the other a lipid bilayer structure [78]. 2H NMR measurements of
speciﬁcally labeled acyl chains of phosphatidylcholine in reconstituted
rhodopsin–bilayer system show only one component [79]. However,
the solid echo used in those experiments decays to an insigniﬁcant in-
tensity when lipids are bound tomembrane proteinswith typical corre-
lation times for rotational diffusion. Therefore the latter technique could
not be expected to reveal a strongly bound lipid component. Solid state
NMR measurements of saturation transfer between protein and lipid
suggest a close approach between phospholipid components and
rhodopsin in reconstituted membranes with a preference for PE in the
vicinity of the protein [80]. Finally chemical labeling experiments to de-
termine accessibility of phospholipid headgroups clearly identify two
phospholipid components in the native disk membrane, one protected
by the protein component [81].
The calcium pump from rabbit sarcoplasmic reticulum transports
calcium against a concentration gradient into the lumen of the sarco-
plasmic reticulum in the muscle. This calcium pump crystallizes with
three PE molecules (per monomer) in the structure [82]. In this case
the headgroups of the PE are well deﬁned while the acyl chains of the
PE are not, suggesting speciﬁc interactions between the headgroup
and the pump protein (Fig. 5). This is emphasized by the observation
of PE bound in each of the sites without contributions from other
phospholipids of the sarcoplasmic reticulum membrane. PE is bound
to the pump at the interfacial region of the protein surface between
Fig. 5. X-ray crystal structure of the rabbit (fast twitch) sarcoplasmic reticulum Ca2+
ATPase (PDB ID: 3W5A) in cyan. Bound PE headgroups appear in blue. The acyl chains
of the PE are not well deﬁned in this structure.
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of the protein.
The calcium pump has also been the subject of study by 31P NMR of
the phospholipid headgroup phosphates [83]. These studies revealed a
component of the phospholipid bound to the pump protein. While it
was not possible to determine the phospholipid composition of the
bound component at that time, the number of bound phospholipids
ranged from 12 phospholipids per pump protein in light sarcoplasmic
reticulum to twice that number in heavy sarcoplasmic reticulum. Direct
observation of two component 31P NMR powder patterns, correspond-
ing to phospholipid headgroups in two different environments, has
been observed in the sarcoplasmic reticulum where the calcium pump
is the major protein component, and in reconstituted membranes con-
taining the pump [84]. 13C NMR experiments with the 13C label in the
phosphatidylcholine headgroup of the pump reconstituted in deﬁned
phospholipid membranes also revealed two components of similar
magnitude to the 31P NMR measurements [85]. Likewise electron spin
resonance measurements with lipid spin labels show evidence of two
lipid components of similar relative magnitude [86,87]. As in the case
of rhodopsin, 2H NMR experiments on reconstituted membranes con-
taining the calcium pump show one component [88]. As noted above,
this is likely the result of rapid decay of the solid echo in those experi-
ments. Another factor is the ability of an acyl chain to move off and
back on the protein when the lipid headgroup is bound to the protein
[89]. Finally other techniques also suggest the presence of two lipid
components in membranes containing the calcium pump. Differential
scanning calorimetry experiments of reconstituted membranes show
two lipid components in the presence of the protein [90]. Phospholipase
digestion experiments also are consistentwith the presence of two lipid
components [86].
The X-ray crystal structure of a bacterial sodium bile acid
cotransporter shows two PE molecules bound per monomer [91]. Both
are bound to the transmembrane helical domain. One is located
between monomers at a contact point and the other is located at a siteaway from the contact point. Both the headgroup and the acyl chains
are deﬁned in the crystal structure.
Aquaporin is responsible for rapid movement of water across a
membrane. Five PEmolecules are found in a crystal structure of aquapo-
rin [92]. The PE molecules are bound to the exterior surface of a tetra-
mer, with the acyl chains lying alongside the transmembrane helices
of the protein [93].
PE exhibits many of the same patterns of binding to membrane
proteins as exhibited by DPG and PG. In some cases, PE appears most
strongly bound to the membrane protein through the headgroup of
the phospholipid. The phosphate in these cases is stabilized in the bind-
ing site by interactions with lysine and arginine side chains, or with
hydroxyls from tyrosine side chains. In other cases, PE is bound to the
membrane protein by strong interaction with acyl chains of the phos-
pholipid. The PE acyl chains may interact with more than one subunit,
thereby possibly stabilizing the quaternary structure of the membrane
protein.
6. Phosphatidylinositol
Phosphatidylinositol (PI) has the inositol in its headgroup and the ino-
sitol can be phosphorylated on the sugar hydroxyls. The various phos-
phorylation states of PI play multiple roles in biology. PI has been found
bound to two transmembrane proteins in X-ray crystal structures. In the
structure of yeast cytochrome bc1 one molecule of PI is bound to the
transmembrane domain, in contact with 4 of 5 subunits with transmem-
brane domains. The inositol is hydrogen bonded to residues on the pro-
tein and the phosphate of the PI forms an ion pair with a conserved
lysine. This PI is suggested to contribute to the stability of the protein [44].
One phosphatidylinositol bisphosphate (PIP2) is found bound to
each subunit of the protein in one of the X-ray crystal structures of the
mammalian GIRK2 potassium channel. PIP2 binds with its acyl chains
in contact with the transmembrane helices of the protein and its
headgroup at the interface between the transmembrane domain and
the extramembraneous domain. The phosphate of the headgroup is
stabilized in the binding site by interactions with more than one lysine
on the protein. This PIP2 enables a conformational change that appears
to be important in the transport function of the protein [94].
One other example of PI binding to a transmembrane protein is
human erythrocyte glycophorin, a transmembrane glycoprotein of the
erythrocyte plasma membrane. At least 3 PI molecules from the
human erythrocyte bind so tightly and speciﬁcally to glycophorin that
when this protein is isolated by detergent treatment, the PI molecules
remain bound. While there is no crystal structure of this protein (the
protein is heavily glycosylated inhibiting crystallization), 31P NMR stud-
ies have been published. Among other experiments, glycophorin was
reconstituted into a lipid bilayer of diglactosyldiglyceride (DGDG).
Since DGDG is a bilayer-forming lipid without phosphate, the only
phospholipid visible in the 31P NMR experiments is the PI. The 31P
powder pattern showed an immobilized lipid with the only degree of
motional freedom that of rotational diffusion of glycophorin to which
the PIwas bound [95]. This is the only example of a 31P NMR experiment
that solely reﬂects the behavior of phospholipids bound to a membrane
protein. This PI is thought to inﬂuence binding of glycophorin with
other proteins associated with the plasma membrane of the human
erythrocyte.
The examples of PI binding to membrane proteins so far available
show the PI headgroup predominating in the lipid–protein interaction.
The phosphate of the headgroup is stabilized in the binding site by in-
teractions with the positively charged amino acid side chain of lysine.
7. Phosphatidylcholine
Phosphatidylcholine (PC) is the last phospholipid for which there
are multiple examples of binding to membrane proteins from X-ray
crystallography. PC is a strong bilayer-forming lipid and the most
Fig. 6. X-ray crystal structure of lens aquaporin (PDB ID: 2B6O) in orange showing several
PC molecules (in cyan) in a conﬁguration approximating a bilayer.
1556 P.L. Yeagle / Biochimica et Biophysica Acta 1838 (2014) 1548–1559common phospholipid in mammalian membranes. The headgroup
consists of a quaternary amine (positive charge) and a phosphate
(negative charge).
One PC is found bound to yeast cytochrome bc1 [44]. The acyl chain
of this PC is bound alongside a transmembrane helix of one of the
subunits, cytochrome b. The phosphate of the headgroup is stabilized
in the binding site by interacting with a nearby histidine from the cyto-
chrome b. In a subsequent study of a less severely delipidated enzyme,
an additional PC binding site was found in the position expected for a
normal lipid bilayer around the protein. This PC binds next to helices
from both cytochrome b and cytochrome c1. The phosphate is stabilized
by interaction with a histidine from cytochrome c1 [65].
In cytochrome c oxidase, PC is bound in a location compatible with a
lipid bilayer around the protein. The acyl chains are bound in a groove
on the surface of the protein. The choline headgroup is in an extended
conformation pointing to what would be the aqueous phase from the
membrane [47].
The X-ray crystal structure of the ADP/ATP carrier protein has two PC
binding sites, one on each side of the protein. In each case, the PC
headgroup is located at the interface between the transmembrane
domain and the extracellular portion of the protein. In one site, the
phosphate of the headgroup is near an arginine. The acyl chains of
the PC lie alongside one of the transmembrane helices of the protein.
The other site is in a position consistent with the opposite leaﬂet
of the lipid bilayer with the headgroup at the interface between the
hydrophobic transmembrane domain and the hydrophilic regions [96].
In squid rhodopsin, one PC is found bound. Its headgroup is bound
underneath helix VIII, a helix that is roughly parallel to the putative
membrane surface plane. Its acyl chains lie along helices I and VII in
the transmembrane domain [97].
In several X-ray crystal structures of transmembrane proteins in
which PC binding sites are identiﬁed, only minimal information is avail-
able about PC binding. PC is found bound at one site on theNa+K+ATPase
in the X-ray crystal structure. The site is near the transmembrane domain
of the protein. Only the headgroup is well deﬁned, suggesting binding
afﬁnity is strongest at the headgroup of PC [98]. PC is also reported in
the X-ray crystal structure of the zinc metalloprotease, ZMPSTE24. The
PC binding site is in the groove deﬁned by two transmembrane helices
of the protein [99]. In the voltage gated channel, NavRh, a PC molecule
is found bound between subunits of this transmembrane protein [100].
In a later crystal structure, 4 PC molecules are found bound, again
between subunits of the protein [101].
Two very different examples of PC molecules in X-ray crystal struc-
tures of membrane proteins address the problem that most X-ray crys-
tal structures of membrane proteins are obtained from delipidated
preparations of the membrane protein to facilitate crystallization.
Sincemuch ofmembrane function depends upon the lipids in themem-
brane, it is important to derive structural information from membrane
proteins in as membrane-like an environment as possible. It was to
this end that the 31P NMR studies described above were directed. 31P
NMR reports on the behavior of the phospholipid headgroups in a
non-perturbing manner. Furthermore, this measurement can be made
on intact biological membranes, not just reconstituted systems or
delipidated protein preparations. Although much can be learned,
the approach has its limitations in that the atomic detail characteristic
of X-ray crystallography is absent.
Therefore the next two studies are of interest in that they are X-ray
crystal structures yet they retain substantial lipid bilayer in the crystal.
Aquaporin is one example (Fig. 6). Structures have been reported
from dimyristoyl PC bilayers and mixed PE, PG, and DPG bilayers. In
each case, the phospholipids are found in a bilayer conﬁguration around
the perimeter of a protein tetramer. The number of phospholipids is suf-
ﬁcient to cover the surface of the transmembrane domain of the protein.
In an extended membrane, this structure would suggest a minimum of
two layers of lipids between tetramers. Biological membranes typically
have 2 to 4 layers of lipids between membrane proteins in the plane ofthe membrane. No particular motif of binding of the phospholipids to
the membrane protein was identiﬁed. Acyl chains adopt a variety
of conformations (though ordered structures) to accommodate the
surface of the transmembrane domain of the protein and the thickness
of the hydrophobic region [102].
Rhomboid protease has been crystallized from bicelles of PC and the
detergent CHAPSO. By crystallizing from an environment that itself
approximates a lipid bilayer, it was hoped to obtain a structure for this
protein more related to the structure in a membrane. Reminiscent of
squid rhodopsin, two PC binding sites are in a pocket underneath two
short helices, H1 and H2, that extend parallel to the membrane surface.
Three additional PC molecules bind in a groove formed by transmem-
brane helices TM1 and TM3. A PC binds in the groove between TM1
and TM2. A PC also binds in the groove between TM2 and TM5. While
other sites are not as well deﬁned, evidence was found for a total of
about 14 PC molecules on the surface of the transmembrane domain
of this protein. These phospholipids approximate the locations expected
for a lipid bilayer [103].
The crystal structure of these membrane proteins that PC binds to
the proteins by interactions with both the headgroup and the acyl
chains. In some cases, the former provides the best deﬁned interactions,
and in other cases, the latter. In the former, thephosphate is stabilized in
the binding site by histidine in one case and arginine in another. In the
latter case, examples exist of acyl chains of PC binding tomore than one
subunit, possibly stabilized quaternary structure of the protein. In other
cases, the acyl chains lie alongside the transmembrane helices in a
groove on the surface.
8. Summary
With over 100 examples of lipid binding sites in the crystal struc-
tures of membrane proteins, some limited motifs emerge for possible
lipid–protein interactions in biological membranes involving those
lipids that are most tightly bound (i.e., so tightly bound that they are
not removed through delipidation by detergents during protein puriﬁ-
cation). In some cases, binding to the membrane protein appears medi-
ated through the entirety of the lipid structure. Cholesterol binding sites
and some phospholipid binding sites provide examples. In other cases,
binding appears dominated by either lipid headgroup interactions
with the membrane protein or interactions between the acyl chains
and the membrane protein.
In the case of mediation of lipid binding through phospholipid
headgroups, most often the negatively charged phosphate is stabilized
by interactions with positively charged amino acid side chains on the
protein. As an alternative in some cases the stabilization is provided
by polar ligands from amino acids rather than full opposite charges.
1557P.L. Yeagle / Biochimica et Biophysica Acta 1838 (2014) 1548–1559The available data do not support a single motif for binding of the lipid
headgroups. Experiments, including the 31P NMR experiments, suggest
that these interactions occur even in biological membranes, not just in
crystals of delipidated proteins.
When mediation of lipid binding is dominated by acyl chain inter-
actions with the protein, the interactions are stabilized by hydrophobic
effects. However, perhaps because of the wide range of amino acid side
chains that are hydrophobic, no consensus for a speciﬁc motif has yet
emerged. Acyl chains of the lipids may be bound on the surface of the
transmembrane domain of the protein. They may be bound to more
than one subunit and thus contribute to the stability of the quaternary
structure. Interestingly in more than one case, the acyl chains of the
lipids penetrate the bundle of helices of the transmembrane domain
of the protein. Here they must play a structural role, but much remains
to be investigated concerning that role.
These X-ray crystal structures do not yet reveal a discernable motif
for cholesterol binding to transmembrane proteins, in contrast to the
CRAC motif for cholesterol binding to other classes of proteins.
Data are available from many studies demonstrating that speciﬁc
membrane lipids modulate membrane function through regulation of
the activity ofmembrane bound enzymes. For example, the essential re-
quirement for cholesterol in mammalian cells can be traced to choles-
terol interactions with membrane proteins, which as can now be seen
in this review, could arise from cholesterol binding to membrane pro-
teins at speciﬁc sites. DPG provides an important parallel example
from the phospholipids. DPG has been shown to be essential for func-
tion of particular mitochondrial enzymes. Those same enzymes have
now been found to have speciﬁc binding sites for DPG in their structure.
Occupation of these binding sites byDPG likely provides themechanism
for DPG modulation of enzyme activity.
From the beginnings of the ﬁeld of studies of structure and function
of biological membranes, investigators have been aware of the co-
existence of lipids and proteins in these membranes [104–106]. It has
been a basic hypothesis driving the study of membranes that these
two classes of compounds must interact with each other in the biologi-
cal membrane in a way that builds the biological functions manifest
from those membranes. As methodologies and technologies have im-
proved over the decades since, data gradually accumulated that support
that hypothesis. Now the advances in X-ray crystallography andelectron
crystallography of transmembrane proteins have givenﬁrm substance to
the hypothesis. At the same time, many experiments published before
the advent of X-ray crystallography of membrane proteins take on
greater signiﬁcance in the light of these more recently available atomic
level structures. The ﬁeld now seems set to explore in detail the struc-
tural and mechanistic origins of the modulation of membrane function
by interactions between membrane lipids and membrane proteins.References
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